The term “DIDMOAD” syndrome – an acronym for the characteristic symptoms – serves as an alternative name for this autosomal recessive neurodegenerative disease, which was first described in 1938: Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness/Deafness. In the majority of patients, mutations in the WFS1 gene can be detected.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Orthobiologics for knee osteoarthritis
PRP and hyaluronic acid injections as building blocks in a multimodal concept
- Soft tissue sarcomas of the lower extremity
Diagnostics, subtypes and treatment options
- Psychological dependence on AI assistants, smartphones and short videos
Algorithms, avatars and the unburdened mind
- Psychooncology
Communication as the key to therapy adherence
- The Brain and the Motivation to Eat
Why is it so hard to lose weight?
- Omaveloxolone for Friedreich's Ataxia
Efficacy and Safety Studied Over 6 Years
- Psoriasis: therapy with biologics and TYK-2-i
Progress assessments based on current long-term and real-world data
- Hypertension: the most important facts for daily practice